Objective-To assess the nature of T cell receptor (TCR) utilisation by CD4 T cells in the rheumatoid joint. Methods-Sequencing of the joining (NDJ) region of TCR i chain mRNA isolated from synovial fluid CD4 T cells was performed in three patients in order to determine if oligoclonal expansion of particular sequences was present. Two patients were studied longitudinally to determine if these sequences changed over time.
the precursor frequency may be too low to be revealed by conventional methods of detecting clonality. Polymerase chain reaction (PCR) based techniques now permit us to analyse small samples with greater sensitivity, in order to establish if clonal expansion has taken place at a sequence level.
Recent studies on the usage of TCRs in RA have shown that joint T cells have frequently undergone clonal expansion, as detected by Southern blotting,3 and by the presence of dominant clonotypes among TCR mRNA transcripts produced by joint T cells. 6 There is, however, less consensus on whether there is preferential utilisation of particular Vot or VP gene families by T cells in the joint. 7 In this study, we have used the PCR to amplify small quantities of synovial TCR cDNA isolated from CD4 T cells, which recognise antigen presented in the context of HLA-DR molecules. We chose to analyse the V112 and V 14 families in particular, as we frequently found their expression to be increased within the joint in preliminary experiments. The clonotypic composition was then analysed by DNA sequencing to determine if TCR expression was oligo-or polyclonal. Further analysis was undertaken in two patients to Tables 1 and 2 give details of the sequences obtained. At least 25 separate plaques were isolated and sequenced from each library. LGGSS YNE2-1 2 (7 7%) n = Total number of sequences analysed for each V family studied. The nucleotide sequences were translated and shown in the single letter amino acid code, and only the last six amino acids of the V segment and the first three amino acids of the J segment utilised are given. The number of times a clonotype was present within the sample is shown, with frequency in o/o. Other clonotypes which only occurred once within the sample are not shown. (table 1) . Four of these six dominant clonotypes were found in high frequency (more than 20% of the total number of transcripts analysed), and accounted for more than 50% of the total number of sequences analysed.
In the first sample obtained from patient 2, four dominant clonotypes were present among 28 V312 transcripts, and four among the 28 V114 transcripts (table 1) . Again, the dominant clonotypes comprised a large proportion of the sequences found.
The first sample from patient 3 Similar results were observed in patient 3, who was re-examined after a three month interval (table 1). In the first aspirate, the clonotypic sequence FCASSPLGD represented more than 52% of the sequences present. In the second aspirate, all the dominant clonotypes present were of low frequency.
Discussion
This study aimed to answer two questions: first, are synovial CD4 T cells activated (and if so, is the activation oligoclonal or polyclonal), and second, does the TCR clonotypic composition change during the course of RA within the same joint? Previous studies have reported clonal expansion of TCR3 transcripts in RA and in patients with seropositive juvenile chronic arthritis (JCA), when unfractionated T cell populations were analysed. 9 Our present findings, although based only on a small sample of patients, confirmed that there are multiple dominant clonotypes present within joint CD4 T cells. We chose to analyse only two VP families using this sequencing strategy, and found dominant clonotypes in each. We defined a dominant clonotype in this study as any sequence present more than once within a particular sample. We do not believe these results to be artefacts arising from the methods used. Our previous control studies6 on sequencing of TCR transcripts from peripheral blood did not show an obvious clonal dominance. Furthermore, sequencing of the VP 14 transcripts of peripheral blood CD4 T cells (30 sequences) from patient 3 showed that all the sequences were entirely different from one another, and no dominant clonotype was observed (data not shown).
Our longitudinal studies in two patients showed that the clonotypic composition within the joint was not static. Large changes in the sequences present were found within the same joint. These results imply that the process of rheumatoid synovial inflammation is dynamic. We cannot exclude an effect of corticosteroids in altering the composition of the T cell population, as they were given at the time of the initial aspirate, but the finding of a changed clonotypic population indicates that T cells bearing different TCRs are capable of participating in synovial inflammation, and they may be recognising different antigens. These results are very different from those obtained by Grom et Alternatively, prior superantigen activation of VP 14-expressing T cells may predispose them to subsequent antigen activation, as has been proposed by Kotzin.4
In conclusion, our results indicate that RA synovial CD4 T cells contain a number of different oligoclonally activated subpopulations, which may be responding to multiple antigens. The population of activated T cells does alter during the course of disease within a particular joint. These results may explain why therapies directed against T cells have not been as successful as originally envisaged, and suggest that continuous suppression of T cell activation would be required to control the local disease effectively.
